About me
Kate Ellmer is an Executive leader at CRISPR Therapeutics where she is responsible for Quality and Pharmacovigilance Operations. In her twenty-year industry career, she has explored her passion for implementing QMS and GxP systems that enable seamless business processes. Kate has led end-to-end QMS implementations at the global level for clinical and commercial organizations through her ability to understand stakeholder requirements and deliver simple, sustainable solutions to meet their needs.
